Revenue dipped 5% to $20 million.
Revenue fell 3% to $32.6 million.
Revenue grew 42% to $19.5 million.
Revenue grew 20% to $58.2 million.
Revenue rose 40% to $17.9 million.
CDC revisits COVID guidelines; Merck’s Januvia may contain traces of carcinogen; Novartis reports death of two children after gene therapy treatment.
Nichol Ochsner arrives at the company from Statera Biopharma.
The company has also introduced a government sector unit.
Chief commercial officer Martyn Hilton will fill the CEO role on an interim basis.
Monkeypox vax doses to be split among patients; Britain lacks booster shot plan; Langya virus infects 35 in China.
Get the most out of
Register for free and enjoy unlimited access to: